Active Biotech
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
ACTI | ST
Overview
Corporate Details
- ISIN(s):
- SE0001137985 (+2 more)
- LEI:
- 549300OJ44CLMRU8YE43
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Active Biotech is a biotechnology company focused on developing pharmaceutical products for medical areas where the immune system is significant, primarily cancer and inflammatory diseases. The company leverages its portfolio of compounds to create novel treatments for specialist indications with high unmet medical need. Its development pipeline includes fully owned projects like tasquinimod for hematological cancers (multiple myeloma, myelofibrosis) and laquinimod for inflammatory eye disorders (non-infectious uveitis). It also has licensed projects, such as naptumomab for solid tumors, which is developed in partnership with NeoTX.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-28 09:32 |
Major Shareholding Notification
|
Swedish | 10.6 KB | ||
| 2025-10-24 10:03 |
Major Shareholding Notification
|
Swedish | 10.6 KB | ||
| 2025-10-17 20:35 |
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA
|
Swedish | 87.2 KB | ||
| 2025-10-17 20:35 |
Pre-Annual General Meeting Information
NOTICE OF EXTRAORDINARY GENERAL MEETING
|
English | 94.1 KB | ||
| 2025-10-17 20:30 |
Share Issue/Capital Change
Active Biotech offentliggör en fullt säkerställd företrädesemission om cirka 70…
|
Swedish | 144.6 KB | ||
| 2025-10-17 20:30 |
Share Issue/Capital Change
Active Biotech announces a fully secured rights issue of approximately SEK 70 m…
|
English | 143.9 KB | ||
| 2025-08-21 08:30 |
Interim Report
|
Swedish | 497.6 KB | ||
| 2025-08-21 08:30 |
Interim Report
|
English | 492.9 KB | ||
| 2025-06-17 15:15 |
Major Shareholding Notification
|
Swedish | 10.7 KB | ||
| 2025-05-28 18:30 |
Post-Annual General Meeting Information
Annual General Meeting of Active Biotech AB
|
English | 76.1 KB | ||
| 2025-05-28 18:30 |
Post-Annual General Meeting Information
Årsstämma i Active Biotech AB
|
Swedish | 74.1 KB | ||
| 2025-05-08 08:30 |
Quarterly Report
|
Swedish | 406.4 KB | ||
| 2025-05-08 08:30 |
Quarterly Report
|
English | 400.9 KB | ||
| 2025-05-05 09:00 |
Regulatory News Service
Active Biotech rapporterar positiva top line-resultat från LION-studien om okul…
|
Swedish | 104.6 KB | ||
| 2025-05-05 09:00 |
Regulatory News Service
Active Biotech reports positive top-line results from the LION study on ocular …
|
English | 104.9 KB |
Automate Your Workflow. Get a real-time feed of all Active Biotech filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Active Biotech
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Active Biotech via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-04-26 | Peter Thelin | Other | Other | 72,783 | N/A |
| 2021-04-26 | Helen Tuvesson Andersson | Other | Buy | 9,589 | 13,961.58 SEK |
| 2021-04-23 | Hans Kolam | Other | Buy | 10,000 | 14,500.00 SEK |
| 2021-03-17 | Helen Tuvesson Andersson | Other | Other | 30,000 | N/A |
| 2021-02-05 | Michael Shalmi | Other | Other | 20,859 | 21,901.95 SEK |
| 2021-01-27 | Michael Shalmi | Other | Other | 46,953 | 49,300.65 SEK |
| 2021-01-18 | Aleksandar Danilovski | Other | Buy | 27,338 | 28,704.90 SEK |
| 2021-01-18 | Aleksandar Danilovski | Other | Buy | 19,675 | 20,658.75 SEK |
| 2020-06-11 | Uli Hacksell | Other | Buy | 21,000 | 57,673.54 SEK |
| 2020-06-11 | Michael Shalmi | Other | Buy | 93,906 | 262,936.80 SEK |
